The combination of CEA-targeting CAR-T cells and rhIL-12 showed superior anti-tumor activity than CEA-targeting CAR-T cells alone in inhibiting the growth of gastric cancer xenografts in mice. This evidence concerns the gene SPRR2A and gastric cancer.